Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Alopecia areata may be linked to imbalanced gut bacteria.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Both mouse and rat models are effective for testing alopecia areata treatments.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Dermoscopy helps diagnose syphilitic alopecia, and treatment with penicillin can regrow hair.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.